GHAYX
Price
$47.95
Change
-$0.30 (-0.62%)
Updated
Oct 7 closing price
Net Assets
533.1M
TRNEX
Price
$43.03
Change
-$0.01 (-0.02%)
Updated
Oct 7 closing price
Net Assets
2.48B
Interact to see
Advertisement

GHAYX vs TRNEX

Header iconGHAYX vs TRNEX Comparison
Open Charts GHAYX vs TRNEXBanner chart's image
VanEck Global Resources Fund Y
Price$47.95
Change-$0.30 (-0.62%)
VolumeN/A
Net Assets533.1M
T. Rowe Price New Era I
Price$43.03
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets2.48B
GHAYX vs TRNEX Comparison Chart in %
View a ticker or compare two or three
VS
GHAYX vs. TRNEX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHAYX is a StrongBuy and TRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.48B vs. GHAYX (533M). GHAYX pays higher dividends than TRNEX: GHAYX (2.46) vs TRNEX (2.01). GHAYX was incepted earlier than TRNEX: GHAYX (15 years) vs TRNEX (10 years). GHAYX (1.18) is less costly to investors than TRNEX (0.57). GHAYX is a more actively managed with annual turnover of: 57.00 vs. TRNEX (24.30). GHAYX has a lower initial minimum investment than TRNEX: GHAYX (1000) vs TRNEX (500000). GHAYX annual gain was more profitable for investors over the last year : 16.64 vs. TRNEX (4.24). GHAYX return over 5 years is better than : 86.66 vs. TRNEX (67.05).
GHAYXTRNEXGHAYX / TRNEX
Total Expense Ratio1.130.57198%
Annual Report Gross Expense Ratio1.180.57207%
Fund Existence15 years10 years-
Gain YTD29.63515.980185%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets533M2.48B22%
Annual Yield % from dividends2.462.01123%
Returns for 1 year16.644.24393%
Returns for 3 years24.5120.28121%
Returns for 5 years86.6667.05129%
Returns for 10 years64.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSCX48.91N/A
N/A
BlackRock Health Sciences Opps Inv C
RDCCX8.81N/A
N/A
Columbia Disciplined Value C
BRZAX13.75N/A
N/A
BlackRock Sust Aware Adg Intl Eq Inv A
OBSOX28.18N/A
N/A
Oberweis Small-Cap Opportunities
HLMVX38.12N/A
N/A
Harding Loevner Global Equity Inst